Effect of chronic hypoxia on fibronectin in plasma, bronchoalveolar lavage fluid and liver of rats

Xu Yong-jian, Abe Tatsuya, Shiraishi Kouichiro, Motomiya Masakichi

Current Medical Science ›› 1992, Vol. 12 ›› Issue (2) : 107-110.

Current Medical Science ›› 1992, Vol. 12 ›› Issue (2) : 107-110. DOI: 10.1007/BF02887791
Article

Effect of chronic hypoxia on fibronectin in plasma, bronchoalveolar lavage fluid and liver of rats

Author information +
History +

Abstract

The present study was undertaken to measure fibronectin (FN) concentration in plasma and bronchoalveolar lavage fluid (BALF) with an enzyme linked immunosorbent assay (ELISA) method, to observe the distribution of FN in liver with an immunohistochemical stain method and to investigate the effect of chronic normobaric hypoxia on them in experimental rats. The results showed that chronic hypoxia caused a significant decrease in plasma FN concentration while BALF FN concentration and the distribution of FN in the liver were not significantly affected, suggesting that the change in FN in. the lower respiratory tract can not be reflected by the change in plasma FN concentration and that the decrease in plasma FN concentration can not be attributed to the change in liver FN secretion. The decrease in plasma FN concentration may lead to a decrease in the defence ability of the body and may contribute to the development of hypercoagulability observed in some patients with chronic hypoxia.

Keywords

fibronectins / hypoxia

Cite this article

Download citation ▾
Xu Yong-jian, Abe Tatsuya, Shiraishi Kouichiro, Motomiya Masakichi. Effect of chronic hypoxia on fibronectin in plasma, bronchoalveolar lavage fluid and liver of rats. Current Medical Science, 1992, 12(2): 107‒110 https://doi.org/10.1007/BF02887791

References

[1.]
MaunderRJ, et al.. Measurement of plasma fibronectin in patients who develop the adult respiratory distress syndrome. J Lab Clin Med, 1984, 104: 583-583
[2.]
YoderMC, et al.. Plasma fibronectin in healthy newborn infants: respiratory distress syndrome and perinatal asphyxia. Pediatrics, 1983, 102: 777-777
CrossRef Google scholar
[3.]
PurvesLR, et al.. Fibronectin levels in normal subjects and patients admitted to a respiratory intensive care unit. S Afr Med J, 1982, 61: 733-733
[4.]
1988;11:15
[5.]
1989;12:343
[6.]
KerrJS, et al.. Reduction of chronic hypoxic pulmonary hypertension in the rat by an inhibitor of collagen production. Am Rev Respir Dis, 1987, 135: 300-300
[7.]
NettelbladtO, et al.. Hyaluronan (hyaluronic acid) in bronchoalveolar lavage fluid during the development of bleomycin induced alveolitis in the rat. Am Rev Respir Dis, 1988, 140: 1028-1028
[8.]
RennardSI, et al.. Enzyme-linked immunoassay (ELISA) for connective tissue components. Analyt Biochem, 1980, 104: 205-205
CrossRef Google scholar
[9.]
BellayY, et al.. An immunocytochemical method for quantification of lung tissue fibronectin. Pro Soc Exp Bio Med, 1988, 188: 159-159
[10.]
TakusagawaK, et al.. Immunoelectron microscopic observations on the localization of fibronectin in normal human lung. Tohoku J Exp Med, 1986, 150: 209-209
CrossRef Google scholar
[11.]
HynesR, et al.. Fibronectin: multifunctional modular glycoproteins. J Cell Biol, 1982, 95: 369-369
CrossRef Google scholar
[12.]
OhE, et al.. Deposition of plasma fibronectin in tissues. Proc Natl Acad Sci USA, 1981, 78: 3128-3128
CrossRef Google scholar
[13.]
1986;9:82

Accesses

Citations

Detail

Sections
Recommended

/